ArticleScience China. Life sciences2026

Engineering probiotics as living biotherapeutics: a novel paradigm of restoring physiological barriers via targeted short-chain fatty acid delivery.

Guangbo Kang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.